Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes (original) (raw)
Low-molecular weight heparins in coronary artery disease
Dan Hunt
Current Atherosclerosis Reports, 2001
View PDFchevron_right
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
Graham Wong
JAMA, 2003
View PDFchevron_right
The use of low-molecular-weight heparins in acute coronary syndromes
Michael Brown
Annals of Emergency Medicine, 2004
View PDFchevron_right
Low-molecular-weight heparins in acute myocardial infarction: RationaLe and results of a pilot study
Karin Coyne
Clinical Cardiology, 2000
View PDFchevron_right
Emergence of Low-Molecular-Weight Heparins in Cardiology
Kathleen Stringer
Pharmacotherapy, 1999
View PDFchevron_right
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
Jerome Premmereur
The New England Journal of Medicine, 1997
View PDFchevron_right
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Petar Kes
Cochrane Database of Systematic Reviews, 2003
View PDFchevron_right
Monitoring of low-molecular-weight heparins in cardiovascular disease
R. Abbate, Guglielmina Pepe
The American Journal of Cardiology, 1998
View PDFchevron_right
Comparison of low-molecular weight heparins to unfractionated heparin
Robert Berent
European Heart Journal, 2001
View PDFchevron_right
Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial
Jerome Premmereur
The American Journal of Cardiology, 1998
View PDFchevron_right
Antithrombotic and bleeding effects of a low molecular weight heparin fraction
Giangiacomo Torri
Biochemical Pharmacology, 1985
View PDFchevron_right
The role of low molecular weight heparin (LMWH) in acute thrombosis (stroke and acute coronary syndrome)
shufrie effendy
2004
View PDFchevron_right
Efficacy and tolerability of a very low molecular weight heparin compared with standard heparin in patients with unstable angina: A pilot study
Luca Sormani
Clinical Cardiology, 1999
View PDFchevron_right
Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes
Lars Wallentin
Clinical Cardiology, 2001
View PDFchevron_right
Low-Molecular-Weight Heparins: Are they all the Same?
Jeffrey Ginsberg
British Journal of Haematology, 2003
View PDFchevron_right
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin
Alberto Quispe
American Heart Journal, 2000
View PDFchevron_right
Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes
Edelmiro Reganon
Haematologica, 2001
View PDFchevron_right
Role of Low-Molecular-Weight Heparin in Invasive Management of Non-ST-Elevation Acute Coronary Syndromes
Lynette Moser
Annals of Pharmacotherapy, 2004
View PDFchevron_right
2 Mechanisms of action of low molecular weight heparins and heparinoids
Fred A Ofosu
Baillière's Clinical Haematology, 1990
View PDFchevron_right
Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis
Francisco Humberto De Abreu Maffei
Pathophysiology of Haemostasis and Thrombosis, 2005
View PDFchevron_right
Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis
Giangiacomo Torri
Journal of Thrombosis and Haemostasis
View PDFchevron_right
The Role of Low-Molecular Weight Heparins in Non-ST Elevation Myocardial Infarction
Idrus Alwi
inaactamedica.org
View PDFchevron_right
Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes
Robert Goldberg
The American Journal of Medicine, 2007
View PDFchevron_right
Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
René G Holzheimer
European journal of medical research, 2004
View PDFchevron_right
Heparin, Low Molecular Weight Heparin, and Derivatives in Thrombosis, Angiogenesis, and Inflammation: Emerging Links
Shaker Mousa
Seminars in Thrombosis and Hemostasis, 2007
View PDFchevron_right
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
Miguel Cerdá, Claudio Garcia
Journal of the American College of Cardiology, 1995
View PDFchevron_right
Improved survival and reduced bleeding with low-molecular-weight heparin across all acute coronary syndrome subsets: findings from the global registry of acute coronary events
Immad Sadiq
Journal of the American College of Cardiology, 2002
View PDFchevron_right
Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin
Peter Nilsson-Ehle
European Journal of Clinical Investigation, 1985
View PDFchevron_right
The Anticoagulant and Nonanticoagulant Properties of Heparin
Gerry Nicolaes
Thrombosis and Haemostasis
View PDFchevron_right
Low-Molecular-Weight Heparins for the Prevention and Treatment of Venous Thromboembolism
Gia Dice
Military Medicine, 2001
View PDFchevron_right
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis
Jeffrey Weitz
The Lancet, 2000
View PDFchevron_right
Another bleeding heart: perioperative heparin management revisited
Christopher Harle
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2007
View PDFchevron_right
The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasis
U. Hedner
Thrombosis Research, 1985
View PDFchevron_right
Prevention of arterial thrombosis using a novel heparin with enhanced antiplatelet activity and reduced anticoagulant activity
Robert F Harris
Journal of Vascular Surgery, 1997
View PDFchevron_right
Preclinical studies on a low molecular weight heparin
Ahmad ridhani ahsan
Thrombosis Research, 1996
View PDFchevron_right